Drugs used for viral myocarditis

By using a specific combination of purslane, isochoria glycoside, and epicatechin gallate, the problem of poor treatment efficacy for viral myocarditis in existing technologies has been solved, achieving multi-target drug therapy effects, significantly improving myocardial function and reducing damage.

CN122124076APending Publication Date: 2026-06-02FOURTH MILITARY MEDICAL UNIVERSITY
View PDF 0 Cites 0 Cited by

Patent Information

Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
FOURTH MILITARY MEDICAL UNIVERSITY
Filing Date
2026-02-05
Publication Date
2026-06-02

Smart Images

  • Figure SMS_4
    Figure SMS_4
  • Figure SMS_5
    Figure SMS_5
  • Figure SMS_6
    Figure SMS_6
Patent Text Reader

Abstract

This invention discloses a drug for viral myocarditis, relating to the field of drug preparation technology. The drug comprises at least one of imperatorin, isochorin, and epicatechin gallate. This drug can effectively inhibit viral replication in myocardial tissue, significantly reduce serum pro-inflammatory factor levels, alleviate inflammatory infiltration, and significantly reduce cell apoptosis, thereby exerting a therapeutic effect on viral myocarditis. This invention solves the problem of the lack of highly effective multi-target viral myocarditis drugs in the prior art.
Need to check novelty before this filing date? Find Prior Art